Growth Metrics

Cardlytics (CDLX) Capital Expenditures (2017 - 2025)

Cardlytics' Capital Expenditures history spans 9 years, with the latest figure at $339000.0 for Q4 2025.

  • For Q4 2025, Capital Expenditures fell 92.14% year-over-year to $339000.0; the TTM value through Dec 2025 reached $480000.0, down 97.29%, while the annual FY2025 figure was $480000.0, 97.29% down from the prior year.
  • Capital Expenditures reached $339000.0 in Q4 2025 per CDLX's latest filing, up from -$300000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $12.5 million in Q3 2024 to a low of -$5.0 million in Q3 2022.
  • Average Capital Expenditures over 5 years is $1.7 million, with a median of $347000.0 recorded in 2021.
  • The largest YoY upside for Capital Expenditures was 24392.16% in 2024 against a maximum downside of 17477.78% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $963000.0 in 2021, then tumbled by 91.59% to $81000.0 in 2022, then soared by 13890.12% to $11.3 million in 2023, then tumbled by 61.94% to $4.3 million in 2024, then tumbled by 92.14% to $339000.0 in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Capital Expenditures are $339000.0 (Q4 2025), -$300000.0 (Q3 2025), and $254000.0 (Q2 2025).